John Andrew Todd, PhD
Affiliations: | Nuffield Department of Medicine | University of Oxford, Oxford, United Kingdom |
Website:
https://www.well.ox.ac.uk/people/john-toddGoogle:
"John Todd"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Atla G, Bonàs-Guarch S, Cuenca-Ardura M, et al. (2022) Genetic regulation of RNA splicing in human pancreatic islets. Genome Biology. 23: 196 |
| Sandholm N, Rubio García A, Pekalski ML, et al. (2022) Thymocyte regulatory variant alters transcription factor binding and protects from type 1 diabetes in infants. Scientific Reports. 12: 14137 |
| Sioofy-Khojine AB, Richardson SJ, Locke JM, et al. (2022) Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage. Diabetologia |
| Robertson CC, Inshaw JRJ, Onengut-Gumuscu S, et al. (2021) Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. Nature Genetics |
| Inshaw JRJ, Sidore C, Cucca F, et al. (2021) Analysis of overlapping genetic association in type 1 and type 2 diabetes. Diabetologia |
| Boughton C, Allen JM, Tauschmann M, et al. (2020) Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol. Bmj Open. 10: e033500 |
| Ramos-Rodríguez M, Raurell-Vila H, Colli ML, et al. (2019) The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes. Nature Genetics |
| Inshaw JRJ, Cutler AJ, Crouch DJM, et al. (2019) Genetic Variants Predisposing Most Strongly to Type 1 Diabetes Diagnosed Under Age 7 Years Lie Near Candidate Genes That Function in the Immune System and in Pancreatic β-Cells. Diabetes Care |
| Ziegler AG, Achenbach P, Berner R, et al. (2019) Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. Bmj Open. 9: e028578 |
| Winkler C, Haupt F, Heigermoser M, et al. (2019) Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results. Pediatric Diabetes |